Efficacy and Safety of Non–Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients With Impaired Liver Function: A Retrospective Cohort Study

BACKGROUND: Patients with impaired liver function (ILF) were excluded from clinical trials that investigated non–vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in patients with atrial fibrillation. The aim of this study was to evaluate the efficacy and safety of NOACs in atri...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Am Heart Assoc
Autors principals: Wang, Chun‐Li, Wu, Victor Chien‐Chia, Kuo, Chang‐Fu, Chu, Pao‐Hsien, Tseng, Hsiao‐Jung, Wen, Ming‐Shien, Chang, Shang‐Hung
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2018
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6201449/
https://ncbi.nlm.nih.gov/pubmed/30371232
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.118.009263
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars